Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This was a randomized, double-blind, parallel group, placebo-controlled study, in two sequential parts that evaluated the renal safety, tolerability and pharmacokinetics of LHW090 in patients with moderately impaired renal function.
Epistemonikos ID: df7bde0029e4f519a1d17d55f0aca7600f441a0d
First added on: May 12, 2024